+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Varicose Veins Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Type, By Component, By End User, By Region and Competition

  • PDF Icon

    Report

  • 116 Pages
  • March 2023
  • Region: Global
  • TechSci Research
  • ID: 5755441
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Global Varicose Veins Treatment Market is anticipated to witness growth of steady CAGR in the forecast period, 2024-2028. It can be ascribed to the rising advanced varicose vein treatment devices escalating the market growth. Besides, surging preference for minimally invasive treatment procedures is expected to drive the growth of global varicose vein treatment market. Additionally, the availability of advanced varicose vein treatment devices is further expected to support market growth. Moreover, the rise in technological advancements and modernization in healthcare devices, and the rise in the research and development activities in the healthcare sector will further create new opportunities for the varicose vein treatment market in the forecasted period. On the contrary, growing R&D and a rise in awareness among healthcare professionals as well as patients regarding varicose vein treatment are expected to create lucrative opportunities in the future. Chronic Venous Insufficiency (CVI) commonly affects lower limbs with a prevalence ranging between 25-40% and 10-20% in women and men, respectively. The annual incidence is 2-6% in women and 1.9% in men.

Rising Prevalence of Venous Disorders

Increasing awareness and the rising prevalence of varicose veins are subsequently boosting market growth. Various governmental and non-governmental organizations are taking initiatives to create awareness about venous diseases and the availability of advanced therapies for their treatment. For instance, in the U.S., recently, the Society for Vascular Surgery and the American Venous Forum issued recommendations for the diagnosis of varicose veins for clinical care. In the U.S. alone, about 30 million people are suffering from varicose veins every year, out of which, only 10% of the people seek treatment. Obesity, particularly among women, prolonged standing hours at work, and smoking, are some of the significant risk factors associated with the development of varicose veins. Additionally, varicose veins are observed to be diagnosed during pregnancies due to the enlargement of the gravid uterus, which results in hypertension and distension in the lower-extremity veins and an increase in hormone secretion, leading to the weakening of the venous walls. The varicose vein is most prevalent in the geriatric population, moreover, rising in the geriatric population is anticipated to boost the market. It is estimated that 41% of women over the age of 50 have varicose veins. It is estimated that 50% of the US population over 50 years old has varicose veins. Women who are moderately overweight (BMI 25-29.9) have a 50% increased risk of developing varicose veins compared to women who are not overweight.

Technological Advancements

The global market is likely to be driven by continuous advancements in varicose veins treatment devices and an increase in the incidence of varicose veins illness. The use of a compression device to treat varicose veins has grown in popularity because it improves blood circulation by applying mild pressure. In addition, various advantages of Laser treatment, such as a painless 30-minute procedure, minimal risk of reoccurrence, minimum invasion, quick recovery, etc., are predicted to help the growth of the Varicose Veins Treatment Market over the projection year. According to the Occupational Safety and Health Research Institute, the prevalence of lower limb varicose veins varies between 10% and 30% globally. Furthermore, in the forecasted period, technical improvements and modernization in healthcare devices increased research and development efforts in the healthcare sector. Increased growth in emerging regions will generate lucrative growth opportunities for the Varicose Veins Treatment Market shortly.

Market Segmentation

The Global Varicose Veins Treatment market is segmented based on type, component, end user, and region. Based on type, the market can be segmented into Endovenous Ablation, Sclerotherapy, Surgical Ligation, and Stripping. Based on components, the market can be differentiated into Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, and Others. Based on end users, the market can be differentiated into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, Europe dominated the market among Asia Pacific, North America, Middle East & Africa, and South America. In terms of country, among United States, North American region is dominating the overall globe in the varicose vein treatment market. Approximately 23% of US adults have varicose veins. If spider telangiectasias and reticular veins are also considered, the prevalence increases to 80% of men and 85% of women.

Market Players

Alma Lasers Limited, Medtronic Plc., Boston Scientific Corporation (Lumenis Corporation), Sciton, Inc., Merit Medical Systems, Inc., BTG International Limited, Energist Limited, Teleflex Incorporated, AngioDynamics, Inc., El. En SpA Group (Quanta System), is some of the leading players operating in the Global Varicose Veins Treatment Market.

Report Scope:

In this report, Global Varicose Veins Treatment market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Varicose Veins Treatment Market, By Type:

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation
  • Stripping

Varicose Veins Treatment Market, By Component:

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Venous Closure Products
  • Others

Varicose Veins Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Varicose Veins Treatment Market, By Region:

  • North America
  • United States
  • Mexico
  • Canada
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Varicose Veins Treatment Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Varicose Veins Treatment Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Endovenous Ablation, Sclerotherapy, Surgical Ligation & Stripping)
5.2.2. By Component (Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, Venous Closure Products, Others)
5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Component
5.3.3. By End User
5.3.4. By Region
6. North America Varicose Veins Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Component
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Varicose Veins Treatment Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Component
6.3.1.2.3. By End User
6.3.2. Mexico Varicose Veins Treatment Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Component
6.3.2.2.3. By End User
6.3.3. Canada Varicose Veins Treatment Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Component
6.3.3.2.3. By End User
7. Europe Varicose Veins Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Component
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Varicose Veins Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Component
7.3.1.2.3. By End User
7.3.2. Germany Varicose Veins Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Component
7.3.2.2.3. By End User
7.3.3. United Kingdom Varicose Veins Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Component
7.3.3.2.3. By End User
7.3.4. Italy Varicose Veins Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Component
7.3.4.2.3. By End User
7.3.5. Spain Varicose Veins Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Component
7.3.5.2.3. By End User
8. Asia-Pacific Varicose Veins Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Component
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Varicose Veins Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Component
8.3.1.2.3. By End User
8.3.2. India Varicose Veins Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Component
8.3.2.2.3. By End User
8.3.3. Japan Varicose Veins Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Component
8.3.3.2.3. By End User
8.3.4. South Korea Varicose Veins Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Component
8.3.4.2.3. By End User
8.3.5. Australia Varicose Veins Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Component
8.3.5.2.3. By End User
9. South America Varicose Veins Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Component
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Varicose Veins Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Component
9.3.1.2.3. By End User
9.3.2. Argentina Varicose Veins Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Component
9.3.2.2.3. By End User
9.3.3. Colombia Varicose Veins Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Component
9.3.3.2.3. By End User
10. Middle East and Africa Varicose Veins Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Component
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Varicose Veins Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Component
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Varicose Veins Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Component
10.3.2.2.3. By End User
10.3.3. UAE Varicose Veins Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Component
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As reported)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. Alma Lasers Limited
13.6.2. Medtronic Plc.
13.6.3. Boston Scientific Corporation (Lumenis Corporation)
13.6.4. Sciton, Inc
13.6.5. Merit Medical Systems, Inc.
13.6.6. BTG International Limited
13.6.7. Energist Limited
13.6.8. Teleflex Incorporated
13.6.9. AngioDynamics, Inc.
13.6.10. El. En SpA Group (Quanta System)
14. Strategic Recommendations

Companies Mentioned

  • Alma Lasers Limited
  • Medtronic Plc.
  • Boston Scientific Corporation (Lumenis Corporation)
  • Sciton, Inc
  • Merit Medical Systems, Inc.
  • BTG International Limited
  • Energist Limited
  • Teleflex Incorporated
  • AngioDynamics, Inc.
  • El. En SpA Group (Quanta System)